229 related articles for article (PubMed ID: 18434519)
1. Bimodal viral vectors and in vivo imaging reveal the fate of human neural stem cells in experimental glioma model.
Shah K; Hingtgen S; Kasmieh R; Figueiredo JL; Garcia-Garcia E; Martinez-Serrano A; Breakefield X; Weissleder R
J Neurosci; 2008 Apr; 28(17):4406-13. PubMed ID: 18434519
[TBL] [Abstract][Full Text] [Related]
2. Imaging fate of stem cells at a cellular resolution in the brains of mice.
Shah K
Methods Mol Biol; 2011; 680():91-101. PubMed ID: 21153375
[TBL] [Abstract][Full Text] [Related]
3. Imaging neural stem cell fate in mouse model of glioma.
Shah K
Curr Protoc Stem Cell Biol; 2009 Mar; Chapter 5():Unit 5A.1. PubMed ID: 19306259
[TBL] [Abstract][Full Text] [Related]
4. Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression.
Shah K; Bureau E; Kim DE; Yang K; Tang Y; Weissleder R; Breakefield XO
Ann Neurol; 2005 Jan; 57(1):34-41. PubMed ID: 15622535
[TBL] [Abstract][Full Text] [Related]
5. Human stem cells expressing novel TSP-1 variant have anti-angiogenic effect on brain tumors.
van Eekelen M; Sasportas LS; Kasmieh R; Yip S; Figueiredo JL; Louis DN; Weissleder R; Shah K
Oncogene; 2010 Jun; 29(22):3185-95. PubMed ID: 20305695
[TBL] [Abstract][Full Text] [Related]
6. Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo.
Tyler MA; Ulasov IV; Sonabend AM; Nandi S; Han Y; Marler S; Roth J; Lesniak MS
Gene Ther; 2009 Feb; 16(2):262-78. PubMed ID: 19078993
[TBL] [Abstract][Full Text] [Related]
7. Visualizing the dynamics of EGFR activity and antiglioma therapies in vivo.
Arwert E; Hingtgen S; Figueiredo JL; Bergquist H; Mahmood U; Weissleder R; Shah K
Cancer Res; 2007 Aug; 67(15):7335-42. PubMed ID: 17671203
[TBL] [Abstract][Full Text] [Related]
8. Iron labeling and pre-clinical MRI visualization of therapeutic human neural stem cells in a murine glioma model.
Thu MS; Najbauer J; Kendall SE; Harutyunyan I; Sangalang N; Gutova M; Metz MZ; Garcia E; Frank RT; Kim SU; Moats RA; Aboody KS
PLoS One; 2009 Sep; 4(9):e7218. PubMed ID: 19787043
[TBL] [Abstract][Full Text] [Related]
9. Cellular multiparametric MRI of neural stem cell therapy in a rat glioma model.
Brekke C; Williams SC; Price J; Thorsen F; Modo M
Neuroimage; 2007 Sep; 37(3):769-82. PubMed ID: 17613248
[TBL] [Abstract][Full Text] [Related]
10. Glioma stem cells involved in tumor tissue remodeling in a xenograft model.
Dong J; Zhang Q; Huang Q; Chen H; Shen Y; Fei X; Zhang T; Diao Y; Wu Z; Qin Z; Lan Q; Gu X
J Neurosurg; 2010 Aug; 113(2):249-60. PubMed ID: 20225923
[TBL] [Abstract][Full Text] [Related]
11. Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin.
Brown AB; Yang W; Schmidt NO; Carroll R; Leishear KK; Rainov NG; Black PM; Breakefield XO; Aboody KS
Hum Gene Ther; 2003 Dec; 14(18):1777-85. PubMed ID: 14670128
[TBL] [Abstract][Full Text] [Related]
12. Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells.
Li S; Tokuyama T; Yamamoto J; Koide M; Yokota N; Namba H
Cancer Gene Ther; 2005 Jul; 12(7):600-7. PubMed ID: 15775995
[TBL] [Abstract][Full Text] [Related]
13. Cyclophosphamide increases transgene expression mediated by an oncolytic adenovirus in glioma-bearing mice monitored by bioluminescence imaging.
Lamfers ML; Fulci G; Gianni D; Tang Y; Kurozumi K; Kaur B; Moeniralm S; Saeki Y; Carette JE; Weissleder R; Vandertop WP; van Beusechem VW; Dirven CM; Chiocca EA
Mol Ther; 2006 Dec; 14(6):779-88. PubMed ID: 16996314
[TBL] [Abstract][Full Text] [Related]
14. Gliomagenesis and the use of neural stem cells in brain tumor treatment.
Achanta P; Sedora Roman NI; Quiñones-Hinojosa A
Anticancer Agents Med Chem; 2010 Feb; 10(2):121-30. PubMed ID: 20184546
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas.
Corsten MF; Miranda R; Kasmieh R; Krichevsky AM; Weissleder R; Shah K
Cancer Res; 2007 Oct; 67(19):8994-9000. PubMed ID: 17908999
[TBL] [Abstract][Full Text] [Related]
16. A 3-dimensional extracellular matrix as a delivery system for the transplantation of glioma-targeting neural stem/progenitor cells.
Hansen K; Müller FJ; Messing M; Zeigler F; Loring JF; Lamszus K; Westphal M; Schmidt NO
Neuro Oncol; 2010 Jul; 12(7):645-54. PubMed ID: 20156807
[TBL] [Abstract][Full Text] [Related]
17. Novel method for visualizing and modeling the spatial distribution of neural stem cells within intracranial glioma.
Lin D; Najbauer J; Salvaterra PM; Mamelak AN; Barish ME; Garcia E; Metz MZ; Kendall SE; Bowers M; Kateb B; Kim SU; Johnson M; Aboody KS
Neuroimage; 2007; 37 Suppl 1():S18-26. PubMed ID: 17560798
[TBL] [Abstract][Full Text] [Related]
18. In vivo tracking of the tropism of mesenchymal stem cells to malignant gliomas using reporter gene-based MR imaging.
Cao M; Mao J; Duan X; Lu L; Zhang F; Lin B; Chen M; Zheng C; Zhang X; Shen J
Int J Cancer; 2018 Mar; 142(5):1033-1046. PubMed ID: 29047121
[TBL] [Abstract][Full Text] [Related]
19. Homing properties of adipose-derived stem cells to intracerebral glioma and the effects of adenovirus infection.
Lamfers M; Idema S; van Milligen F; Schouten T; van der Valk P; Vandertop P; Dirven C; Noske D
Cancer Lett; 2009 Feb; 274(1):78-87. PubMed ID: 18842332
[TBL] [Abstract][Full Text] [Related]
20. Human neural stem cells genetically modified to overexpress Akt1 provide neuroprotection and functional improvement in mouse stroke model.
Lee HJ; Kim MK; Kim HJ; Kim SU
PLoS One; 2009; 4(5):e5586. PubMed ID: 19440551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
